MoneyWorks4Me

Ipca Laboratories reports Profit after tax of Rs 2756.80 Mln, in the September 2020 quarter

07 Nov 2020 Evaluate
The company witnessed a 7.03% growth in the revenue at Rs. 12977.70 millions for the quarter ended September 2020 as compared to Rs. 12125.60 millions during the year-ago period.The company has announced a 40.64% increase in its profits to Rs . 2756.80  millions for the  quarter ended September 2020 compared to Rs. 1960.20 millions in the corresponding quarter in the previous year.Operating Profit saw a handsome growth to 3751.60 millions from 2758.90 millions in the quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202009 201909 % Var 202009 201909 % Var 202003 201903 % Var
Sales 12977.70 12125.60 7.03 27830.20 22235.70 25.16 43674.30 36331.50 20.21
Other Income 150.00 143.30 4.68 266.90 337.60 -20.94 646.90 545.90 18.50
PBIDT 3751.60 2758.90 35.98 9747.90 4903.60 98.79 9794.50 7477.60 30.98
Interest 18.10 40.50 -55.31 42.70 85.20 -49.88 157.90 184.90 -14.60
PBDT 3733.50 2718.40 37.34 9705.20 4818.40 101.42 9636.60 7292.70 32.14
Depreciation 462.60 451.10 2.55 914.90 871.50 4.98 1786.90 1718.80 3.96
PBT 3270.90 2267.30 44.26 8790.30 3946.90 122.71 7849.70 5573.90 40.83
TAX 514.10 307.10 67.40 1497.10 666.20 124.72 1325.10 1024.80 29.30
Deferred Tax -6.90 -18.10 -61.88 -38.90 -24.00 62.08 -54.70 -124.00 -55.89
PAT 2756.80 1960.20 40.64 7293.20 3280.70 122.31 6524.60 4549.10 43.43
Equity 252.70 252.70 0.00 252.70 252.70 0.00 252.70 252.70 0.00
PBIDTM(%) 28.91 22.75 27.05 35.03 22.05 58.83 22.43 20.58 8.96
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..